Title : Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis - Sellam_2016_Arthritis.Res.Ther_18_294 |
Author(s) : Sellam J , Riviere E , Courties A , Rouzaire PO , Tolusso B , Vital EM , Emery P , Ferraccioli G , Soubrier M , Ly B , Hendel Chavez H , Taoufik Y , Dougados M , Mariette X |
Ref : Arthritis Res Ther , 18 :294 , 2016 |
Abstract : Sellam_2016_Arthritis.Res.Ther_18_294 |
ESTHER : Sellam_2016_Arthritis.Res.Ther_18_294 |
PubMedSearch : Sellam_2016_Arthritis.Res.Ther_18_294 |
PubMedID: 27964756 |
Sellam J, Riviere E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferraccioli G, Soubrier M, Ly B, Hendel Chavez H, Taoufik Y, Dougados M, Mariette X (2016)
Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis
Arthritis Res Ther
18 :294
Sellam J, Riviere E, Courties A, Rouzaire PO, Tolusso B, Vital EM, Emery P, Ferraccioli G, Soubrier M, Ly B, Hendel Chavez H, Taoufik Y, Dougados M, Mariette X (2016)
Arthritis Res Ther
18 :294